“…Several FGFs, including Fgf8, Fgf10 and Fgf18 are expressed in the developing ventral diencephalon around 9.5-10.5 dpc (Treier et al, 1998(Treier et al, , 2001, and loss-of-function mutants of FGF and FGFR2 demonstrate that FGF signalling is required for normal proliferation of RP progenitors and pituitary morphogenesis (De Moerlooze et al, 2000;Ohuchi et al, 2000). Ex vivo culture of RP tissue exposed to FGFs and FGF inhibitors has revealed a crucial function for the pathway in controlling both RP proliferation, and its downregulation is required for normal PIT1-cell lineage specification (Ericson et al, 1998;Norlin et al, 2000). Of note, transgenic ectopic expression of Fgf8 in the developing pituitary using a Cga (a-GSU) promoter results in pituitary hyperplasia and expansion of ACTH-expressing cells (corticotrophs and melanotrophs) with a concomitant severe loss of gonadotrophs, somatotrophs, thyrotrophs and gonadotrophs (Treier et al, 1998), a phenotype resembling our mouse models that activate the MAPK-ERK pathway.…”